A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome

Experimental Dermatology

Volumn 21, Issue 12, 2012, Pages 967-969

  Nagy, Nikoletta ^a   Farkas, Katalin ^a   Kinyo, Ágnes ^a   Nemeth, Istvan B ^a   Kis, Erika ^a   Varga, János ^a   Bata Csorgo, Zsuzsanna ^a   Kemeny, Lajos ^a   Szell, Márta ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Appendage tumor; Brooke Spiegler syndrome; CYLD gene; NEMO protein; Ubiquitination

Indexed keywords

CYLD PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AUTOSOMAL DOMINANT DISORDER; BROOKE SYNDROME; CANCER SURGERY; CASE REPORT; ENZYME ACTIVITY; EXON; FEMALE; GENE; GENE IDENTIFICATION; GENETIC CODE; HEAD AND NECK TUMOR; HETEROZYGOTE; HISTOLOGY; HUMAN; HUNGARY; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MISSENSE MUTATION; PAPULE; PEDIGREE; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; UBIQUITINATION;

ADULT; FAMILY HEALTH; FEMALE; HUMANS; HUNGARY; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84869987239     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12040     Document Type: Letter

References (27)

1. Evans C D. Br J Dermatol 1954: 66: 434-443.
2. Bignell G R, Warren W, Seal S et al. Nat Genet 2000: 25: 160-165.
3. Blake P W, Toro J R. Hum Mutat 2009: 30: 1025-1036.
4. Sima R, Vanecek T, Kacerovska D et al. Diagn Mol Pathol 2010: 19: 83-91.
5. Kazakov D V, Vanecek T, Zelger B et al. Am J Dermatopathol 2011: 33: 251-265.
6. Linos K, Schwartz J, Kazakov D V et al. Am J Dermatopathol 2011: 33: 640-642.
7. van den Ouweland A M, Elfferich P, Lamping R et al. Fam Cancer 2011: 10: 127-132.
8. Chen M, Liu H, Fu X et al. Australas J Dermatol 2011: 52: 146-147.
9. Ponti G, Nasti S, Losi L et al. J Cutan Pathol 2012: 39: 366-371.
10. Rajan N, Burn J, Langtry J et al. J Pathol 2011: 224: 309-321.
11. Shi Y. Structure 2008: 16: 338-340.
12. Trompouki E, Hatzivassiliou E, Tsichritzis T et al. Nature 2003: 424: 793-796.
13. Chapard C, Hohl D, Huber M. Exp Dermatol 2012: 21: 321-326.
14. Kovalenko A, Chable-Bessia C, Cantarella G et al. Nature 2003: 424: 801-805.
15. Brummelkamp T R, Nijman S C, Dirac A M et al. Nature 2003: 424: 797-801.
16. Tauriello D V, Haegebarth A, Kuper I et al. Mol Cell 2010: 37: 607-619.
17. Reiley W W, Zhang M, Jin W et al. Nat Immunol 2006: 7: 411-417.
18. Jin W, Reiley W R, Lee A J et al. J Biol Chem 2007: 282: 15884-15893.
19. Tsagaratou A, Grammenoudi S, Mosialos G. Eur J Immunol 2011: 41: 3054-3062.
20. Zhao Y, Thornton A M, Kinney M C et al. J Biol Chem 2011: 286: 40520-40530.
21. Tsagaratou A, Trompouki E, Grammenoudi S et al. J Immunol 2010: 185: 2032-2043.
22. Lee A J, Wu X, Cheng H et al. J Biol Chem 2010: 285: 15696-15703.
23. Reiley W W, Jin W, Lee A J et al. J Exp Med 2007: 204: 1475-1485.
24. Hövelmeyer N, Wunderlich F T, Massoumi R et al. J Exp Med 2007: 204: 2615-2627.
25. Reiley W W, Zhang M, Jin W et al. Nat Immunol 2006: 7: 411-417.
26. Srokowski C C, Masri J, Hövelmeyer N et al. Blood 2009: 113: 5891-5895.
27. Saeki Y, Kudo T, Sone T et al. EMBO J 2009: 28: 359-371.